Ischemic preconditioning and lipopolysaccharide attenuate nuclear factor-κB activation and gene expression of inflammatory cytokines in the ischemia-reperfused rat heart

Japanese Circulation Journal

Volumn 65, Issue 11, 2001, Pages 984-990

  Hiasa, G ^a   Hamada, M ^a   Ikeda, S ^a   Hiwada, K ^a  

^a EHIME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Inflammatory cytokines; Ischemia reperfusion; Ischemic preconditioning; Lipopolysaccharide; Nuclear factor B

Indexed keywords

CYTOKINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; MESSENGER RNA; TUMOR NECROSIS FACTOR; AUTACOID;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; DOWN REGULATION; ENZYME ACTIVATION; GENE EXPRESSION; HEART INFARCTION PREVENTION; HEART INFARCTION SIZE; HEART MUSCLE ISCHEMIA; HEART MUSCLE REPERFUSION; INFLAMMATION; MALE; NONHUMAN; PROTEIN BINDING; PROTEIN DETERMINATION; RAT; ANIMAL; BIOSYNTHESIS; CHEMISTRY; DISEASE MODEL; DRUG EFFECT; GENETICS; HEART INFARCTION; HEART MUSCLE; IMMUNOHISTOCHEMISTRY; METABOLISM; RAT STRAIN;

ANIMAL; CYTOKINES; DISEASE MODELS, ANIMAL; DOWN-REGULATION; GENE EXPRESSION; IMMUNOHISTOCHEMISTRY; INFLAMMATION MEDIATORS; ISCHEMIC PRECONDITIONING, MYOCARDIAL; LIPOPOLYSACCHARIDES; MALE; MYOCARDIAL INFARCTION; MYOCARDIAL ISCHEMIA; MYOCARDIAL REPERFUSION; MYOCARDIUM; NF-KAPPA B; RATS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER;

EID: 0034768584     PISSN: 00471828     EISSN: None     Source Type: Journal    
DOI: 10.1253/jcj.65.984     Document Type: Article

References (40)

1. NF-kappa B ten years after
2. Nuclear factor-κB: A pivotal transcription factor in chronic inflammatory diseases
3. Inhibition of nuclear factor κB attenuates proinflammatory cytokine and inducible nitric-oxide synthase expression in postischemic myocardium
4. Cytokine mRNA expression in postischemic/reperfused myocardium
5. Cytokine signaling during myocardial infarction: Sequential appearance of IL-1β and IL-6
6. Cardiac release of cytokines and inflammatory responses in acute myocardial infarction
7. Cytokine gene expression after myocardial infarction in rat hearts: Possible implication in left ventricular remodeling
8. Role of cytokines and adhesion molecules in ischemia and reperfusion in patients with acute myocardial infarction
9. Reduction of myocardial infarct size by inhibition of inducible nitric oxide synthase
10. Tumor necrosis factor in the heart
11. In vivo transfection of cis element "decoy" against nuclear factor-κB binding site prevents myocardial infarction
12. Preconditioning with ischemia: A delay of lethal cell injury in ischemic myocardium
13. Ischemic preconditioning reduces infarct size in swine myocardium
14. Effect of preconditioning ischemia on reperfusion arrhythmias after coronary artery occlusion and reperfusion in the rat
15. Preconditioning causes improved wall motion as well as smaller infarcts after transient coronary occlusion in rabbits
16. The transient nature of the effect of ischemic preconditioning on myocardial infarct size and ventricular arrhythmia
17. Ischemic preconditioning protects against infarction in rat heart
18. Preconditioning ischemia time determines the degree of glycogen depletion and infarct size reduction in rat hearts
19. Biochemical and ultrastructural evaluations of the effect of ischemic preconditioning on ischemic myocardial injury: Role of the adenosine triphosphate-sensitive potassium channel
20. Adenosine and cardioprotection in the diseased heart
21. Toward the heart of ischemic preconditioning
22. Ischaemic preconditioning: Present position and future directions
23. Ischemic preconditioning decreases postischemic myocardial tumor necrosis factor-α production: Potential ultimate effector mechanism of preconditioning
24. Endotoxin and ischemic preconditioning: TNF-α concentration and myocardial infarct development in rabbits
25. Effects of induced tolerance to bacterial lipopolysaccharide on myocardial infarct size in rats
26. Increased levels of myocardial kappaB-alpha protein promote tolerance to endotoxin
27. Delayed protection against ischemia-induced ventricular arrhythmias and infarct size limitation by the prior administration of Escherichia coli endotoxin
28. Rapid detection of octamer binding proteins with 'mini-extracts', prepared from a small number of cells
29. Activation of mitogen-activated protein kinases and activator protein-1 in myocardial infarction in rats
30. Early activation of transcription factor NF-κB during ischemia in perfused rat heart
31. Demonstration of free radical generation in 'stunned' myocardium of intact dogs with the use of the spin trap alpha-phenyl N-tert-butyl nitrone
32. Expression and regulation of adhesion molecules in cardiac cells by cytokines: Response to acute hypoxia
33. Cytokines and cardiomyocyte death
34. Induction of interleukin-6 synthesis in the myocardium: Potential role in postreperfusion inflammatory injury
35. Neutrophil adherence to isolated adult cardiac myocytes: Induction by cardiac lymph collected during ischemia and reperfusion
36. Transcription factor decoy for nuclear factor-κB inhibits tumor necrosis factor-α-induced expression of interleukin-6 and intracellular adhesion molecule-1 in endothelial cells
37. Nuclear factor-κB plays an essential role in the late phase of ischemic preconditioning in conscious rabbits
38. Adenosine prevents activation of transcription factor NF-kappa B and enhances activator protein-1 binding activity in ischemic rat heart
39. An essential role of NF-κB in tyrosine kinase signaling of p38 MAP kinase regulation of myocardial adaptation to ischemia
40. Reactive oxygen species function as second messenger during ischemic preconditioning of heart